[BidClub_]

SHOW DIRECTORY

Sourcery

Molly O'Shea interviews leading investors, CEOs, and founders about technology companies, markets, and company building.

SOURCE DESCRIPTION · RSS

53 EPISODESENTRACKED SHOW
SUBSCRIBE[Feed_]
20 episodes2 active
Language
SourceryEN · 51 min

Dylan Patel, SemiAnalysis

Dylan PatelMolly O'Shea

Permits have pushed gigawatts of capacity from 2027 into 2028, while Patel sees no space-based relief for three or four years.Persistent agents now take 45% of his company’s $15 million annual AI spend, mostly via Perplexity Computer using Claude and OpenAI.Better harnesses can redirect usage, but Harvey’s fluctuating margins and uncertain Perplexity take leave durable economics unresolved.

SourceryEN · 66 min

Dylan Patel's SemiAnalysis Empire: $500M Fund, Citrini & NVIDIA?

Dylan PatelMolly O'Shea

SemiAnalysis shifted multiple gigawatts of data-center capacity from 2027 into 2028 as permits remain unavailable, while Patel expects space to add little capacity before “maybe 2030.”Patel says new very high-end chips will not be approved for China, and scrutiny could extend to GPU rentals; rental access may preserve demand while shifting business toward approved providers or AMD.Persistent agents rose to 45% of SemiAnalysis’s $50 million annual AI spend, mostly through Perplexity Computer using Claude and OpenAI, but margins and customer retention remain unresolved.

SourceryEN · 61 min

SpaceX, Palantir, Anduril & Onodrim | The Return of Conglomerates

Molly O'SheaChristian Garrett

SpaceX’s roughly 160% Q3 revenue growth and sub-12-month compute paybacks bolster Garrett’s view of a vertically integrated hyperscaler with several growth engines.He places SpaceX at roughly 20–30× EBITDA on a $2 trillion valuation, while arguing that ownership across applications, models and infrastructure offers flexibility as AI economics shift.The thesis still hinges on uncertain future demand and financing; Starship’s expected order-of-magnitude launch-cost reduction could open new businesses, but full reusability remains a key economic milestone.

SourceryEN · 44 min

Inside $17B Index Ventures: Anthropic, Wiz, Datadog & the Future of AI

Molly O'SheaShardul Shah

Bloomberg’s January 2026 figures put Index’s 2012 fund at 11X DPI versus a 1.5X industry average, and its $780 million 2015 growth fund at 5.1X.Shah says a roughly 25% valuation gap should not stop a deal; with model advances every few months unsettling AI retention, adaptable founders become central to durability.

SourceryEN · 66 min

I Got Interviewed! The Story Behind Sourcery, Alex Karp, Sam Altman Clip..

Paige Finn DohertyMolly O'Shea

Sourcery grew from O’Shea’s internal funding tracker into a public research archive, with LinkedIn bringing most subscribers.She favors broad promotion over exclusives, estimating 90% of interview work happens afterward; announcement timing helped early podcast traction.Behind Genius has backed over 60 companies across three funds, emphasizing “technical storytellers”; Doherty says Knox Metals’ visibility drives orders and investor interest.

SourceryEN · 42 min

Franklin Templeton CEO on SpaceX, Anthropic, Circular Deals & the State of the Market

Jenny JohnsonMolly O'Shea

Johnson favors shorter-term AI financing: today’s cash-generative borrowers differ from internet-bubble firms, but 20- or 30-year data-center debt risks locking in current chip and energy needs.Franklin Templeton’s late-stage SpaceX and Anthropic stakes seek missed IPO returns, but illiquid holdings may stay at 6%, 7% or 8% against a 15% limit.

SourceryEN · 56 min

Apollo’s Yahoo Playbook, 5 Years After the $5B Deal

Jim LanzoneMolly O'Shea

Lanzone says Apollo has largely recovered its $4.8 billion Yahoo cost through early cash returns and disposals including AOL.The reset shut loss-making ad tech that cost hundreds of millions annually and opened inventory to competing demand, while retaining DSP.Scout restores owned search, but Lanzone makes no IPO commitment and hesitates to call Yahoo’s audience distribution a moat.

SourceryEN · 70 min

Thrive Capital’s Dr. Nworah Ayogu on Why Neuralink Is More Interesting Than SpaceX

Molly O'SheaNworah Ayogu

Thrive’s healthcare thesis is that AI may shift bottlenecks from molecule generation to validation, trials, manufacturing, and commercialization.Cadence cites 25% fewer hospitalizations, over-80% more controlled-blood-pressure patients, nearly one-point lower A1C, and $2.5 million in weekly Medicare savings across 100,000+ monitored patients.Neuralink and OpenAI show upside, while clinical processes and manufacturing capacity remain unresolved constraints.

SourceryEN · 85 min

USV’s New $900M Fund: Fred Wilson, Rebecca Kaden & Mike Mignano

Fred WilsonRebecca KadenMichael MignanoMolly O'Shea

USV’s $900 million fund targets 30-40 companies with $10 million-$30 million Series A checks as larger rounds and scaling costs reshape venture.Its AI thesis spans applications, infrastructure, physical AI, and energy, while usage retention, compute costs, inference subsidies, distribution, interoperability, trust, and leadership concentration remain key tests.

SourceryEN · 58 min

Annie Lamont: $14B Managed, 70+ Exits, 15 IPOs, 7x Midas Investor

Jonathan SiddharthMolly O'Shea

Healthcare AI has crossed O'Shea’s threshold for measurable impact, with biological and chemical models, laboratory robotics and simulations targeting drug development’s high failure rates.After a decade building licenses, networks and care infrastructure, Devoted Health tripled in size, halved operating expenses and significantly increased EBITDA, while China’s rising pharmaceutical research share leaves domestic research and regulatory capacity as risks to monitor.